ArticleOncotarget2016

Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.

Yinghan Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.